Patients' value of asthma services in Australian pharmacies: The way ahead for asthma care

Naik-Panvelkar, P; Armour, C; Rose, J; Saini, B

Patients' value of asthma services in Australian pharmacies: The way ahead for asthma care

Naik-Panvelkar, P Armour, C Rose, J Saini, B

Permalink

Publication Type:: Journal Article
Citation:: Journal of Asthma, 2012, 49 (3), pp. 310 - 316
Issue Date:: 2012-04-01

Closed Access

	Filename	Description	Size
	Patients Value of Asthma Services in Australian Pharmacies The Way Ahead for Asthma Care.pdf	Published Version	485.89 kB	Adobe PDF	View/Open

Copyright Clearance Process

Recently Added
In Progress
Closed Access

This item is closed access and not available.

Full metadata record

Field	Value	Language
dc.contributor.author	Naik-Panvelkar, P	en_US
dc.contributor.author	Armour, C	en_US
dc.contributor.author	Rose, J	en_US
dc.contributor.author	Saini, B	en_US
dc.date.issued	2012-04-01	en_US
dc.identifier.citation	Journal of Asthma, 2012, 49 (3), pp. 310 - 316	en_US
dc.identifier.issn	0277-0903	en_US
dc.identifier.uri	http://hdl.handle.net/10453/115315
dc.description.abstract	Objective. Long-term sustainability of health services requires an understanding of patients' values and preferences. The aim of this study was to evaluate patients' preferences as well as their willingness-to-pay (WTP) for a community pharmacy-delivered specialized asthma service using a discrete choice experiment (DCE). Methods. Patients with asthma in New South Wales, Australia, who had recently experienced a specialized asthma management service at their pharmacy were mailed DCE questionnaires. Patients were asked to choose between two hypothetical service models with varying attributes. Multinomial logit models estimated patients' marginal WTP. Results. The study had a response rate of 47%. Patients greatly valued various aspects of the pharmacy-based specialized service and had marginal WTP values of AUD$18.00 for a private area, AUD$44.50 for lung function testing, AUD$9.18 for appointments with pharmacists, and AUD$22.80 for provision of comprehensive advice on asthma and its medications. The marginal WTP for the overall service was AUD$94.86. Conclusions. The findings of the study indicate that patients greatly value and are willing to pay for asthma services in pharmacies. The study results will help pharmacists and policy advisors in the development of individualized asthma services that patients will use, are willing to pay for, and thus are economically viable in the future. © 2012 Informa Healthcare USA, Inc.	en_US
dc.relation.ispartof	Journal of Asthma	en_US
dc.relation.isbasedon	10.3109/02770903.2012.658130	en_US
dc.subject.classification	Allergy	en_US
dc.subject.mesh	Humans	en_US
dc.subject.mesh	Asthma	en_US
dc.subject.mesh	Respiratory Function Tests	en_US
dc.subject.mesh	Questionnaires	en_US
dc.subject.mesh	Professional-Patient Relations	en_US
dc.subject.mesh	Choice Behavior	en_US
dc.subject.mesh	Age Factors	en_US
dc.subject.mesh	Sex Factors	en_US
dc.subject.mesh	Adult	en_US
dc.subject.mesh	Aged	en_US
dc.subject.mesh	Middle Aged	en_US
dc.subject.mesh	Educational Status	en_US
dc.subject.mesh	Income	en_US
dc.subject.mesh	Community Pharmacy Services	en_US
dc.subject.mesh	Financing, Personal	en_US
dc.subject.mesh	Appointments and Schedules	en_US
dc.subject.mesh	Delivery of Health Care	en_US
dc.subject.mesh	Australia	en_US
dc.subject.mesh	New South Wales	en_US
dc.subject.mesh	Female	en_US
dc.subject.mesh	Patient Education as Topic	en_US
dc.subject.mesh	Patient Preference	en_US
dc.subject.mesh	Surveys and Questionnaires	en_US
dc.title	Patients' value of asthma services in Australian pharmacies: The way ahead for asthma care	en_US
dc.type	Journal Article
utslib.citation.volume	3	en_US
utslib.citation.volume	49	en_US
utslib.for	1103 Clinical Sciences	en_US
utslib.for	1117 Public Health and Health Services	en_US
pubs.embargo.period	Not known	en_US
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Faculty of Business
pubs.organisational-group	/University of Technology Sydney/Strength - BIDA - Business Intelligence and Data Analytics
utslib.copyright.status	closed_access
pubs.issue	3	en_US
pubs.publication-status	Published	en_US
pubs.volume	49	en_US

Abstract:

Objective. Long-term sustainability of health services requires an understanding of patients' values and preferences. The aim of this study was to evaluate patients' preferences as well as their willingness-to-pay (WTP) for a community pharmacy-delivered specialized asthma service using a discrete choice experiment (DCE). Methods. Patients with asthma in New South Wales, Australia, who had recently experienced a specialized asthma management service at their pharmacy were mailed DCE questionnaires. Patients were asked to choose between two hypothetical service models with varying attributes. Multinomial logit models estimated patients' marginal WTP. Results. The study had a response rate of 47%. Patients greatly valued various aspects of the pharmacy-based specialized service and had marginal WTP values of AUD$18.00 for a private area, AUD$44.50 for lung function testing, AUD$9.18 for appointments with pharmacists, and AUD$22.80 for provision of comprehensive advice on asthma and its medications. The marginal WTP for the overall service was AUD$94.86. Conclusions. The findings of the study indicate that patients greatly value and are willing to pay for asthma services in pharmacies. The study results will help pharmacists and policy advisors in the development of individualized asthma services that patients will use, are willing to pay for, and thus are economically viable in the future. © 2012 Informa Healthcare USA, Inc.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/115315